GlassScriptPhysician profile
Sachin Narain
NPI 1790009231
$31,294.41
in general payments reported to CMS, 2019-2025
36 companies · $6,536 in 2025
The $6,536 reported for 2025 was more than what 92% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,003 · 2020: $3,120 · 2021: $2,045 · 2022: $2,858 · 2023: $4,582 · 2024: $11K · 2025: $6,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $6,137 · Travel and Lodging: $1,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,296.88 |
| Food and Beverage | $6,137.01 |
| Travel and Lodging | $1,834.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,960.29 | 2019-2025 | Proclaim, Prodigy, Eterna |
| Spinefrontier, INC. | $2,463.35 | 2023-2025 | Sacrix, Inspan, Nanofuse |
| Impactortho, INC. | $2,192.51 | 2020 | |
| Painteq LLC | $1,253.33 | 2021-2024 | Painteq |
| Boston Scientific Corporation | $1,167.41 | 2019-2025 | Superion Indirect Decompression System, Intracept, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $583.84 | 2019-2022 | |
| Vertos Medical, INC. | $399.50 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $296.15 | 2019-2025 | Relistor |
| Biotronik Nro, INC. | $225.79 | 2024-2025 | Prospera |
| Nalu Medical, INC. | $201.85 | 2021-2023 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $199.64 | 2019-2020 | |
| Protega Pharmaceutials INC | $174.55 | 2023-2025 | Roxybond |
| Almatica Pharma LLC | $137.07 | 2021-2023 | Gralise |
| Scilex Pharmaceuticals INC. | $130.24 | 2019-2024 | |
| Acacia Pharma INC | $120.60 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alevio, LLC | $108.11 | 2023 | Sicure Sacroiliac Joint Fusion System |
| Pfizer INC. | $84.29 | 2019-2020 | |
| Curonix LLC | $80.42 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Foundation Fusion Solutions, LLC | $51.49 | 2023-2024 | |
| Allergan, INC. | $50.84 | 2021 | |
| Abbvie INC. | $48.53 | 2022 | |
| Stimwave Technologies Incorporated | $46.00 | 2019-2020 | |
| Saluda Medical Americas, INC. | $40.20 | 2025 | Evoke |
| Relievant Medsystems, INC. | $39.26 | 2023 | Intracept |
| Collegium Pharmaceutical, INC. | $32.27 | 2019-2022 | |
| Orthogenrx INC. | $27.52 | 2021 | |
| Si-Bone, INC. | $25.98 | 2019 | |
| Daiichi Sankyo INC. | $19.97 | 2019 | |
| Convatec INC. | $19.67 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $18.94 | 2025 | |
| Shionogi INC | $18.89 | 2019 | |
| Globus Medical, INC. | $18.80 | 2025 | Senza |
| Redhill Biopharma INC. | $15.73 | 2020 | |
| Zyla Life Sciences, INC. | $15.41 | 2020 | |
| Ibsa Pharma INC. | $13.77 | 2024 | Licart, Tirosint |
| Arbor Pharmaceuticals, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sachin Narain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.